EE03513B1 - Klopidogreeli ja tromboosivastast ühendit sisaldavad uued toimeainete kombinatsioonid - Google Patents

Klopidogreeli ja tromboosivastast ühendit sisaldavad uued toimeainete kombinatsioonid

Info

Publication number
EE03513B1
EE03513B1 EE9800247A EE9800247A EE03513B1 EE 03513 B1 EE03513 B1 EE 03513B1 EE 9800247 A EE9800247 A EE 9800247A EE 9800247 A EE9800247 A EE 9800247A EE 03513 B1 EE03513 B1 EE 03513B1
Authority
EE
Estonia
Prior art keywords
pct
active substances
substances containing
new combinations
antithrombotic compound
Prior art date
Application number
EE9800247A
Other languages
English (en)
Estonian (et)
Other versions
EE9800247A (et
Inventor
Bernat Andr�
Herbert Jean-Marc
Savi Pierre
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03513(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi filed Critical Sanofi
Publication of EE9800247A publication Critical patent/EE9800247A/xx
Publication of EE03513B1 publication Critical patent/EE03513B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
EE9800247A 1996-02-19 1997-02-17 Klopidogreeli ja tromboosivastast ühendit sisaldavad uued toimeainete kombinatsioonid EE03513B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
PCT/FR1997/000296 WO1997029753A1 (fr) 1996-02-19 1997-02-17 Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique

Publications (2)

Publication Number Publication Date
EE9800247A EE9800247A (et) 1999-02-15
EE03513B1 true EE03513B1 (et) 2001-10-15

Family

ID=9489354

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800247A EE03513B1 (et) 1996-02-19 1997-02-17 Klopidogreeli ja tromboosivastast ühendit sisaldavad uued toimeainete kombinatsioonid

Country Status (29)

Country Link
US (1) US5989578A (pt)
EP (1) EP0881901B1 (pt)
JP (1) JP3662028B2 (pt)
KR (1) KR100295345B1 (pt)
CN (1) CN1116042C (pt)
AT (1) ATE218870T1 (pt)
AU (1) AU715655B2 (pt)
BR (1) BR9707556A (pt)
CA (1) CA2246289C (pt)
CZ (1) CZ292363B6 (pt)
DE (2) DE69713287T2 (pt)
DK (1) DK0881901T3 (pt)
EE (1) EE03513B1 (pt)
ES (1) ES2176684T3 (pt)
FR (1) FR2744918B1 (pt)
HK (1) HK1017850A1 (pt)
HU (1) HU225036B1 (pt)
IL (1) IL125848A (pt)
IS (1) IS1892B (pt)
NO (2) NO317747B3 (pt)
NZ (1) NZ331444A (pt)
PL (1) PL187292B1 (pt)
PT (1) PT881901E (pt)
RU (1) RU2184547C2 (pt)
SI (1) SI0881901T1 (pt)
SK (1) SK284285B6 (pt)
TR (1) TR199801608T2 (pt)
UA (1) UA51695C2 (pt)
WO (1) WO1997029753A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002506024A (ja) * 1998-03-13 2002-02-26 メルク エンド カムパニー インコーポレーテッド 急性冠動脈虚血症候群および関連状態に対する併用療法および組成物
PT1087775E (pt) 1998-06-17 2005-11-30 Bristol Myers Squibb Co Prevencao de enfarte cerebral por administracao de uma combinacao de farmacos antiplaquetarios bloqueadores de receptores de adp e anti-hipertensivos
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
EP1350511B1 (en) 2000-12-25 2008-09-10 Daiichi Sankyo Company, Limited Medicinal compositions containing aspirin
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
US20040067995A1 (en) * 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel
US7790362B2 (en) * 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
EP1926736A4 (en) * 2005-09-21 2010-08-25 Chong Kun Dang Pharm Corp NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
KR20150041173A (ko) * 2007-04-27 2015-04-15 사이덱스 파마슈티칼스, 인크. 클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법
CN101951896B (zh) * 2008-02-22 2012-11-28 韩兀生物制药株式会社 复合制剂
DE102008032361A1 (de) 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
KR101743591B1 (ko) 2009-05-13 2017-06-20 사이덱스 파마슈티칼스, 인크. 프라수그렐 및 사이클로덱스트린 유도체를 포함하는 약학 조성물 및 그의 제조 및 사용 방법
KR20120050437A (ko) 2009-06-25 2012-05-18 테트라, 시아 신규한 아세틸살리실산 염들
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
WO2013133620A1 (en) * 2012-03-09 2013-09-12 Yuhan Corporation Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
EP2796145B1 (en) 2013-04-22 2017-11-01 CSL Ltd. A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
WO2015015062A1 (fr) * 2013-08-02 2015-02-05 Sanofi Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
ES2176684T3 (es) 2002-12-01
AU1884497A (en) 1997-09-02
RU2184547C2 (ru) 2002-07-10
DE122010000030I1 (de) 2010-10-21
HU225036B1 (en) 2006-05-29
BR9707556A (pt) 1999-07-27
HUP9901144A2 (hu) 1999-09-28
NO317747B3 (no) 2011-10-03
DE69713287D1 (de) 2002-07-18
HUP9901144A3 (en) 2001-04-28
UA51695C2 (uk) 2002-12-16
KR100295345B1 (ko) 2001-08-07
PL327923A1 (en) 1999-01-04
CN1211922A (zh) 1999-03-24
PL187292B1 (pl) 2004-06-30
CZ292363B6 (cs) 2003-09-17
NZ331444A (en) 2001-04-27
CA2246289C (fr) 2003-12-16
DE69713287T2 (de) 2002-12-19
NO317747B1 (no) 2004-12-13
CN1116042C (zh) 2003-07-30
SK284285B6 (sk) 2005-01-03
WO1997029753A1 (fr) 1997-08-21
SI0881901T1 (en) 2002-10-31
FR2744918A1 (fr) 1997-08-22
EP0881901B1 (fr) 2002-06-12
CA2246289A1 (fr) 1997-08-21
PT881901E (pt) 2002-09-30
HK1017850A1 (en) 1999-12-03
NO983812L (no) 1998-10-09
ATE218870T1 (de) 2002-06-15
EP0881901A1 (fr) 1998-12-09
DK0881901T3 (da) 2002-10-07
NO2010015I1 (no) 2010-07-26
SK110598A3 (en) 1999-01-11
CZ249998A3 (cs) 1998-11-11
US5989578A (en) 1999-11-23
IL125848A (en) 2000-11-21
IL125848A0 (en) 1999-04-11
JP3662028B2 (ja) 2005-06-22
DE122010000030I2 (de) 2012-06-21
EE9800247A (et) 1999-02-15
NO2010015I2 (no) 2012-11-12
NO983812D0 (no) 1998-08-19
TR199801608T2 (xx) 1998-11-23
KR19990087163A (ko) 1999-12-15
FR2744918B1 (fr) 1998-05-07
IS1892B (is) 2003-10-20
AU715655B2 (en) 2000-02-10
JPH11510818A (ja) 1999-09-21
IS4827A (is) 1998-08-18

Similar Documents

Publication Publication Date Title
EE03513B1 (et) Klopidogreeli ja tromboosivastast ühendit sisaldavad uued toimeainete kombinatsioonid
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
FI973279A (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
BR9607862A (pt) Composição farmacêutica filmogênica para administração transdérmica
SE9504661D0 (sv) New compounds
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
DK1167354T3 (da) Racemisk huperzin A
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
PT101444A (pt) Associacao sinergizante com efeito antagonista dos receptores nk1 e nk2, uso de produtos com actividade antagonista dos receptores nk1 e nk2 na sua preparacao e composicao farmaceutica contendo a referida associacao
PT862575E (pt) Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
IL110724A0 (en) Retroviral protease inhibitors, their preparation and pharmaceutical compositions containing them
FI963394A0 (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
SE9504662D0 (sv) New compounds
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
HUP9903619A2 (hu) 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
FR2715564B1 (fr) Composition pharmaceutique contenant de la N-acétyl-cystéine.
IT9048605A0 (it) Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
ITMI930181A0 (it) Composizione farmaceutica contenente n-acetil-cisteina
ITMI922832A1 (it) DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO.
ITMI911444A1 (it) Derivati dell'eserolina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizuini farmaceutiche che li contengono.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

AA1Y Spc filed

Free format text: PRODUCT NAME: DUOPLAVIN - KLOPIDROGREEL/ATSETUEUEL-SALITSUEUELHAPE; REG NO/DATE: C(2010)1817 15.03.2010

Spc suppl protection certif: C20100005

Filing date: 20100513

FG1Y Spc granted

Free format text: PRODUCT NAME: DUOPLAVIN - KLOPIDROGREEL/ATSETUEUEL-SALITSUEUELHAPE; REG NO/DATE: C(2010)1817 15.03.2010

Spc suppl protection certif: C20100005 00031

Filing date: 20100513

Extension date: 20220217

KB4A Valid patent at the end of a year

Effective date: 20101231

MC1Y Annulment of an spc

Spc suppl protection certif: 00031